Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

BUY
$19.14 - $24.55 $14,622 - $18,756
764 Added 30.98%
3,230 $63,000
Q2 2021

Jul 30, 2021

SELL
$52.03 - $68.77 $29,396 - $38,855
-565 Reduced 18.64%
2,466 $161,000
Q4 2020

Jan 28, 2021

BUY
$27.19 - $44.68 $29,446 - $48,388
1,083 Added 55.6%
3,031 $135,000
Q2 2020

Jul 28, 2020

BUY
$32.85 - $53.77 $28,743 - $47,048
875 Added 81.55%
1,948 $69,000
Q1 2019

Apr 29, 2019

SELL
$90.12 - $152.23 $18,294 - $30,902
-203 Reduced 15.91%
1,073 $102,000
Q4 2018

Jan 25, 2019

BUY
$112.83 - $239.74 $12,636 - $26,850
112 Added 9.62%
1,276 $158,000
Q2 2018

Aug 06, 2018

SELL
$123.8 - $192.48 $15,351 - $23,867
-124 Reduced 9.63%
1,164 $217,000
Q4 2017

Jan 31, 2018

BUY
$93.4 - $128.74 $35,398 - $48,792
379 Added 41.69%
1,288 $153,000
Q3 2017

Nov 08, 2017

BUY
$91.08 - $104.49 $82,791 - $94,981
909
909 $86,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $193M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.